Device Support Specialist (Washington, DC)
Novocure Inc | |
United States, D.C., Washington | |
Aug 14, 2026 | |
|
Description: The Device Support Specialist (DSS) is responsible for supporting commercial oncology patients utilizing the Tumor Treating Fields (TTFields) device. The DSS may also be required to assist with clinical trial oncology patients as needed. The DSS is a full-time, exempt, field based position reporting to the Regional Manager, Device Support Specialist. ESSENTIAL DUTIES AND RESPONSIBILITIES:
QUALIFICATIONS/KNOWLEDGE:
OTHER:
WHAT WE OFFER This pay range which Novocure expects to pay for this role at the time of this posting is $55,000 - $70,000/yr. This position may also be eligible for an annual bonus and restricted stock unit grant in addition to a full range of benefits. Individual compensation within this range depends on a variety of factors, including, but not limited to, prior education and experience, job-related knowledge and skills demonstrated. ABOUT NOVOCURE: Our vision Patient-forward: aspiring to make a difference in cancer. Our patient-forward mission Together with our patients, we strive to extend survival in some of the most aggressive forms of cancer by developing and commercializing our innovative therapy. Our patient-forward values - innovation - focus - drive - courage - trust - empathy Novocure is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sexual orientation, gender identity, age, national origin, disability, protected veteran status or other characteristics protected by federal, state, or local law. We actively seek qualified candidates who are protected veteran and individuals with disabilities as defined under VEVRAA and Section 503 of the Rehabilitation Act. Novocure is committed to providing an interview process that is inclusive of our applicant's needs. If you are an individual with a disability and would like to request an accommodation, please email NovocureRecruitingEEO@novocure.com | |
Aug 14, 2026